Washington University School of Medicine, Center for Advanced Medicine

St Louis, Missouri 63110

1 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumors, CRC, Colorectal Cancer, Cutaneous or Subcutaneous Lymph Node, Gastrointestinal Stromal Tumor (GIST), Glioblastoma, Hepatocellular Carcinoma, KRAS/NRAS Mutation, Liver Metastases, Liver Tumors, Metastatic Colorectal Cancer, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Clinical Study of YL205 in Patients With Advanced Solid Tumors — Recruiting now
• Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation — Running, not enrolling
• A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) — Completed
• Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation — Completed
• Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 — Completed
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed
• Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) — Completed